Tech Company Financing Transactions
Apnimed Funding Round
Apnimed, based in Cambridge, scored $25 million in investment from Morningside Group, J. & W. Seligman & Co. and Tao Capital Partners.
Transaction Overview
Company Name
Announced On
3/26/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds will support Apnimed's ongoing development and commercialization plans.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Holyoke St.
Cambridge, MA 02138
USA
Cambridge, MA 02138
USA
Phone
Website
Email Address
Not Recorded
Overview
Apnimed was built upon a simple idea -- patients with Obstructive Sleep Apnea (OSA) need a safe and effective medication that addresses the underlying biology of the disease. OSA is a serious disorder in which the upper airway partly or completely closes during sleep.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Miller
Chief Financial Officer
Michael Rogers
Chief Medical Officer
Ron Farkas
Chief Operating Officer
Dennis Molnar
Chief Scientific Officer
Luigi Montemurro
VP - Bus. Development
Barry Wohl
Browse more venture capital transactions:
Prev: 3/26/2021: Ketch venture capital transaction
Next: 3/26/2021: Pie Insurance venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs